CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

STAT News
Original article

STAT+: AstraZeneca opens new Boston site 

Positive
AI Analysis

Summary

AstraZeneca opened a new R&D site in Boston's Kendall Square, representing a $1 billion investment in U.S. biotechnology infrastructure.

Importance:3/10
Sentiment:
0.60
facility expansionR&D investmentBostonKendall Square
Related Companies

Read the original article

Published by STAT News on October 6, 2026 2:41 PM

Read Original